Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 22
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01799941 | Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA) | ||
| NCT01667679 | Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura | ||
| NCT01787747 | Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy Volunteers | ||
| NCT02402595 | Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult Subejcts | ||
| NCT01767129 | Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients | ||
| NCT00573443 | Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS | ||
| NCT00021697 | Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS | ||
| NCT01584440 | Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease | ||
| NCT01324232 | Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis | ||
| NCT01366027 | PRISM Registry: Pseudobulbar Affect Registry Series | ||
| NCT00113620 | Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy | ||
| NCT00050232 | Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients | ||
| NCT02174835 | A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers | ||
| NCT02153502 | Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment | ||
| NCT02534038 | Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition | ||
| NCT02477670 | Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia | ||
| NCT02176018 | Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine | ||
| NCT02336347 | A Phase 1 Study Comparing AVP-786 With AVP-923 | ||
| NCT03381664 | Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult Participants | ||
| NCT01832350 | Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease | ||
| NCT00056524 | Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) | ||
| NCT02496039 | Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA) |
